Ketamine Breakthrough

New York Times best-selling author Dr. Mike Dow and Ronan Levy, founder of Field Trip, the world's largest provider of psychedelic-assisted psychotherapies, offer ways to integrate ketamine into treatment for depression, anxiety, PTSD, and more It's the most impactful revolution in mental health since the introduction of Prozac in 1986- ketamine-assisted psychotherapy (KAP).  Ketamine and other psychedelic-assisted psychotherapies, once considered taboo, are now frequently featured in The New York Times and other prestigious publications. When combined with psychotherapy, ketamine, which has been described as the being possibly the "most important breakthrough in antidepressant treatment in decades," has the potential to treat depression, anxiety, PTSD, and other debilitating mental illnesses-and change lives. Unlike antidepressants, which merely mask the pain, psychedelics that heal the brain are the future. Instead of putting Band-Aids on the brain, with KAP, we can actually repair the neurological damage caused by neglect, stress, and abuse. In this book, best-selling author Dr. Mike Dow and Field Trip co-founder and executive chairman Ronan Levy provide a broad overview of where ketamine-assisted psychotherapy came from, how it works, who it works for, and what to expect. This book will outline key moments in scientific history that have paved the way for KAP's future, and go through its specific protocol for both practitioners and patients. This book contains hope for those diagnosed with treatment-resistant depression, plagued by trauma and frozen by fears. Ketamine-assisted psychotherapy has also proven effective for people with drug, alcohol, and behavioral addictions, existential depression, grief, and just feeling stuck. People with unresolved resentments, anger, and the everyday anxieties of modern life will also benefit. Ketamine-assisted psychotherapy has been enormously helpful with couples, groups, and veterans, which will be addressed in the book as well. This is the go-to manual for therapists and anyone considering or undergoing KAP treatment.